Physician profile
Eric D Shapiro
NPI 1083636476
$777.83
in general payments reported to CMS, 2019-2025
13 companies · $63.22 in 2025
The $63.22 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $27.54 · 2021: $56.25 · 2022: $14.02 · 2023: $143 · 2024: $72.29 · 2025: $63.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $153.12 | 2019-2024 | Exparel, Iovera, Zilretta |
| Medical Device Business Services, INC. | $115.11 | 2019 | |
| Inari Medical, INC. | $113.67 | 2019 | |
| Edwards Lifesciences Corporation | $88.22 | 2023 | Hemosphere, Pascal |
| Medtronic, INC. | $77.22 | 2023-2025 | Invos, Bis |
| Boston Scientific Corporation | $67.23 | 2019-2024 | Watchman Flx |
| Merck Sharp & Dohme LLC | $45.46 | 2019-2024 | Bridion |
| Chiesi USA, INC. | $31.96 | 2020-2023 | Cleviprex, Kengreal |
| La Jolla Pharmaceutical Company | $27.62 | 2019 | |
| Cardiva Medical, INC. | $21.75 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Fisher & Paykel Healthcare INC | $14.42 | 2024 | Fisher & Paykel Healthcare |
| Baudax Bio INC. | $14.02 | 2022 | |
| Ambu INC. | $8.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.